| http://www.w3.org/ns/prov#value | - ???Monitoring of liver enzymes before and during treatment is recommended for patients with underlying hepatic disease, including hepatitis B or C infection; patients with marked transaminase elevations; and patients treated with other medications associated with liver toxicity. ??? Liver enzyme monitoring should also be considered for patients without pre-existing hepatic dysfunction or other ris
|
